Edwards Lifesciences: The Winning Streak Continues (EW)
Shares of Edwards Lifesciences (NYSE:EW) traded today at $118.92, breaking its 52-week high. So far today approximately 223,000 shares have been exchanged, as compared to an average 30-day volume of 1.9 million shares.
Edwards Lifesciences Corporation designs, develops, manufactures, and markets products and services to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards supplies its products to customers located worldwide.
In the past 52 weeks, shares of Edwards Lifesciences have traded between a low of $61.38 and a high of $118.92 and are now at $117.70, which is 92% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.5% while the 200-day MA has risen 0.7%.
There is potential upside of 46.9% for shares of Edwards Lifesciences based on a current price of $117.70 and an average consensus analyst price target of $172.89. Edwards Lifesciences shares have support at the 50-day moving average (MA) of $96.47 and additional support at the 200-day MA of $81.36.
SmarTrend recommended that subscribers consider buying shares of Edwards Lifesciences on July 11th, 2016 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $105.13. Since that recommendation, shares of Edwards Lifesciences have risen 12.3%. We continue to monitor EW for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows edwards lifesciences